Our gel.
Your API.
The system enables a sustained-release profile that enhances:
Oral bioavailability, improving absorption and reducing API requirements and overall cost.
Pharmacokinetic profiles, minimising peak-to-trough ratios and improving tolerability.
Consistency, decreasing variability in uptake and ensuring more reliable therapeutic outcomes.
The system can also reduce dosing frequency, for example transforming a once-daily pill into a once-weekly treatment.
The system is suitable for both small molecules and peptides
